<DOC>
	<DOCNO>NCT02514122</DOCNO>
	<brief_summary>A randomized double blind control trial investigate safety efficacy subcutaneous ketamine control post operative pain low resource setting .</brief_summary>
	<brief_title>Subcutaneous Ketamine Postoperative Pain Relief Rwanda</brief_title>
	<detailed_description>A randomized double blind control trial . All patient undergo upper abdominal , thoracic , gynecologic orthopaedic surgery Centre Hospitalier Universitaire de Kigali , Kigali , Rwanda invite participate . Enrolled patient receive subcutaneous ketamine ( placebo ) administer immediately surgery , even surgery , every 12 hour thereafter total 5 injection dose 1mg/kg . The primary outcome reduction mean Pain Scores use parametric statistical analysis discriminate significance . Pain measure use 11-point numerical rating scale . Secondary outcome presence significant side effect . This trial partnership University Saskatchewan National University Rwanda ethic approval institution ethic board .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>All patient undergo upper abdominal , thoracic , gynecologic orthopaedic surgery one month period expect post operative hospital admission Allergy Ketamine History narcotic abuse dependence Those patient decrease cognitive function barrier accurate data collection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>